Literature DB >> 18457956

Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation.

Herko Grubitzsch1, Christian Grabow, Helmut Orawa, Wolfgang Konertz.   

Abstract

OBJECTIVE: Treatment of atrial fibrillation, a risk factor for morbidity and mortality, by left atrial ablation is a less complex procedure which is increasingly performed in conjunction with surgery for various heart diseases. Although restoration of sinus rhythm is effective initially, atrial fibrillation may recur. We investigated factors predicting the time until its recurrence.
METHODS: Between January 2003 and December 2005, 162 consecutive patients (52.5% male, age 69+/-8.7 years) with permanent atrial fibrillation underwent concomitant left atrial ablation and isolated or combined mitral valve surgery (42.6%), isolated or combined aortic valve surgery (32.1%), and isolated or combined coronary artery bypass grafting (24.1%). Ablation was performed by microwave (n=93, 57.4%) or radiofrequency (n=69, 42.6%) technology. Follow-up was after 3, 6, 12 months and yearly thereafter. Predictive values of variables for postoperative atrial fibrillation were examined using techniques of univariate and multivariate survival analysis (proportional hazards regression).
RESULTS: Eight patients died perioperatively and 13 during follow-up (not ablation related). Two patients were lost to follow-up. At last follow-up (19+/-11.3 months), 86 patients (62%) were in stable sinus rhythm, 73 (52%) without antiarrhythmic drugs, and 43 (31%) were in atrial fibrillation. Predictors for the time until recurrence of atrial fibrillation in a multivariate model were preoperative atrial fibrillation duration (hazard ratio 1.005, 95% confidence interval 1.003-1.007, p<0.001) and left atrial diameter (hazard ratio 1.056, 95% confidence interval 1.020-1.093, p=0.002). Overall, sinus rhythm conversion rate was 75% when preoperative atrial fibrillation duration was less than 2 years, but 42% in longer lasting atrial fibrillation with left atrial dilatation (>50mm). Age, gender, primary heart disease, history of thromboembolism or cardioversion, presence of concomitant diseases, EuroScore, left ventricular size and function, aortic cross-clamp time, ablation technology, and treatment with antiarrhythmic drugs did not predict rhythm outcome.
CONCLUSIONS: Preoperative atrial fibrillation duration and left atrial diameter predict the time until atrial fibrillation recurrence after concomitant left atrial ablation, whereas age, type of primary cardiac surgery, ablation technology and antiarrhythmic therapy do not.

Entities:  

Mesh:

Year:  2008        PMID: 18457956     DOI: 10.1016/j.ejcts.2008.03.054

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Left atrial pressure and dominant frequency of atrial fibrillation in humans.

Authors:  Kentaro Yoshida; Magnus Ulfarsson; Hakan Oral; Thomas Crawford; Eric Good; Krit Jongnarangsin; Frank Bogun; Frank Pelosi; Jose Jalife; Fred Morady; Aman Chugh
Journal:  Heart Rhythm       Date:  2010-10-26       Impact factor: 6.343

2.  Impact of left atrial appendage ridge ablation on the complex fractionated electrograms in persistent atrial fibrillation.

Authors:  Shiro Nakahara; Yuichi Hori; Akiko Hayashi; Sayuki Kobayashi; Hidehiko Nakamura; Yasuo Okumura; Kan Takayanagi
Journal:  J Interv Card Electrophysiol       Date:  2014-07-27       Impact factor: 1.900

Review 3.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

4.  Use of acoustic cardiography immediately following electrical cardioversion to predict relapse of atrial fibrillation.

Authors:  Paul Erne; Therese J Resink; Andrea Mueller; Michael Coslovsky; Richard Kobza; David Conen; Peter Bauer; Patricia Arand
Journal:  J Atr Fibrillation       Date:  2017-06-30

Review 5.  Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Miki Yokokawa; Hakan Oral; Aman Chugh
Journal:  J Atr Fibrillation       Date:  2012-10-06

6.  Does the expression of transforming growth factor β-1: affect the outcome of the radiofrequency modified maze procedure in patients with rheumatic atrial fibrillation?

Authors:  Wei Wang; Lei Liu; Yuan Li; Sheng-Shou Hu; Yun-Hu Song; Xin Wang
Journal:  Tex Heart Inst J       Date:  2012

7.  Analysis of Bipolar Radiofrequency Ablation in Treatment of Atrial Fibrillation Associated with Rheumatic Heart Disease.

Authors:  Xiliang Zhu; Qian Li; Yang Li; Zhong Wu
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

8.  Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation.

Authors:  Ang Li; Yue Chen; Wei Wang; Li Su; Zhiyu Ling
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-07-05       Impact factor: 1.468

9.  Concomitant Atrial Fibrillation Procedures During Cardiac Surgery in a UK Center: Reflection of Worldwide Practice?

Authors:  Alina-Adriana Mistirian; Martin T Yates; Wael I Awad
Journal:  Front Cardiovasc Med       Date:  2022-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.